Cognition Therapeutics’ dementia drug showed up to a 129% slowing of cognitive decline in mild Alzheimer’s disease patients ...

While often seen as a gift, high intelligence can come with its own unique set of challenges, particularly when navigating a ...

ALZpath’s pTau217 antibody was released in 2023 and continues to be a key focus in Alzheimer’s disease research and ...

Eisai (ESALF) and Eli Lilly (LLY) post new long-term data for thier Alzheimer's drugs Leqembi and Kisunla, respectively. Read more here.

TORONTO -- The antiviral agent valacyclovir demonstrated no benefit in early Alzheimer's disease, the phase II VALAD trial ...

As limited aid reaches Gaza, experts warn that malnutrition and starvation is causing long-term, irreversible harm to ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

From skipping breakfast to multitasking, some everyday habits may be silently damaging your brain. Discover 6 lesser-known ...

Sabi pipo dey warn say risk of famine dey high for Gaza as one out of evri three pipo for dia dey go for days witout anytin ...

SaveHealth reports migraines are complex neurological conditions affecting over a billion globally, requiring comprehensive ...

Leaded gasoline was a dominant fuel source for decades around the world, preventing engine knocking and allowing for better ...